• Home
  • >>>>>>>>>>>>> 2026 & BEYOND MASTER PLAN >>>>>>>>>>>>>>>>
  • TRAINABLE DATA ASSETS IN CORPORATE LEGACY & ORGANIZATION’s STRATEGIC MEMORY (2012 – 2025)
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Founder’s Vision
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder’s Bio
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2025 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • Blockchain Transactions Network Ecosystem
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • SOP Web STAT
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM
  • BioMed Audio Podcast Library @LPBI Group
  • Medical School Education: Use of LPBI Group’s Contents
  • ChatGPT + Wolfram PlugIn
  • Medicine with GPT-4 & ChatGPT
  • AGI, generativeAI, Grok, DeepSeek & Expert Models in Healthcare
  • Multimodal Healthcare Foundation Model
  • Cell Therapy in Regenerative Medicine, 2026 and Beyond
  • Contact Us

Leaders in Pharmaceutical Business Intelligence Group, LLC, Doing Business As LPBI Group, Newton, MA

Healthcare analytics, AI solutions for biological big data, providing an AI platform for the biotech, life sciences, medical and pharmaceutical industries, as well as for related technological approaches, i.e., curation and text analysis with machine learning and other activities related to AI applications to these industries.

Feeds:
Posts
Comments

M3DP

10/6/2015 NEWS

The 15th Annual EmTech MIT, November 2–4, 2015, MIT Media Lab, Cambridge, MA

Explores technologies highlighted in the recent 10 Breakthrough Technologies list and celebrates the 2015 Innovators Under 35.

Live Press Coverage: Aviva Lev-Ari, PhD, RN

http://www.technologyreview.com/emtech/15/

http://pharmaceuticalintelligence.com/2015/10/06/the-15th-annual-emtech-mit-november-2-4-2015-mit-media-lab-cambridge-ma/

Wednesday, November 4 — 3D Printing @The 15th Annual EmTech MIT

9:00 Disruptive Entrepreneurship: 3D Printing

Skylar Tibbits
Director, MIT Self-Assembly Lab
Innovation in 3-D Printing

Shawn DuBravac
Chief Economist and Head of Research, Consumer Electronics Association
2016 Trends: Entrepreneurship in 3D Printing

  • Medical 3D BioPrinting – M3DP

  • http://pharmaceuticalintelligence.com/medical-3d-printing/

Matrix Organization

http://pharmaceuticalintelligence.com/2015/08/26/lpbis-m3dp-matrix-organization/

Repository of Resources on M3DP

http://pharmaceuticalintelligence.com/2015/08/18/repository-for-lpbis-initiative-on-medical-3d-printing/

HQS – Boston, MA

HQS – Lausanne, Switzerland

OUR CURRENT PLAN FOR FUNDING GDE’s

Medical 3D BioPrinting (M3DP)

Development of IP and PPA in the domain of 3D BioPrinting

Active prospecting for Private Equity Investment

Dr. Pearlman – Cardiovascular and other Medical Devices – PPA on 3D Printing of Stents coated by EPCs and NO, (Aviva has prior art.)

Bill Zurn – Development of MEMS and 3D Printing is UNDER GDE’s M3DP

Dr. Nir, SBH Sciences – Cytokines

Any development of Hydrogel and Cytokines using 3D BioPrinting is UNDER GDE’s M3DP

NEW  – Dr. Codrington, Cambridge, UK – Diagnostics, Antibodies in Hematology) – Candidate for Foundation Funding

NEW  – Dr. Evelyna Cohn

Biochemical and Nanopartics COATINGS using 3D BioPrinting: applications for Protective Equipment for RNA Viruses: Ebola, AMATRAX, others

  • In collaboration with GDE’s M3DP, using 3D Printing
  • Potential PPA with Dr. Pearlman on MASKS or entire system: Uniform + Mask – Candidate for Foundation Funding

On 9/23/2015: NEW Content Created by Team members on M3DP

How 3D Printing Can Save a Life

Curator: Danut Dragoi, PhD

http://pharmaceuticalintelligence.com/2015/09/23/how-3d-printing-can-save-a-life/

Augmentation of the ONTOLOGY of the 3D Printing Research

Curator: Larry H. Bernstein, MD, FCAP

http://pharmaceuticalintelligence.com/2015/09/21/augmentation-of-the-ontology-of-the-3d-printing-research/

Series E: Volume Two, Chapter 9. 3-D Printing and Medical Application

9.1 3-D Printing

Larry H. Bernstein, MD

http://pharmaceuticalintelligence.com/2015/09/10/3-d-printing/

9.2 What is 3D printing?

Larry H. Bernstein, MD

http://pharmaceuticalintelligence.com/2015/09/10/what-is-3-d-printing/

9.3 The Scientist Who Is Making 3D Printing More Human

Larry H. Bernstein, MD

http://pharmaceuticalintelligence.com/2015/09/10/the-scientist-who-is-making-3d-printing-more-human/

9.4 Join These Medical 3D Printing Groups on Twitter and LinkedIn for great up to date news

Curator: Stephen J. Williams, Ph.D.

http://pharmaceuticalintelligence.com/2015/08/22/join-these-medical-3d-printing-groups-on-twitter-and-linkedin/

9.5 MIT researchers invent process for 3D-printing complex transparent glass forms

Aviva Lev-Ari, PhD, RN; sourced through Scoop It from www.Kurzweil.net

http://pharmaceuticalintelligence.com/2015/08/23/mit-researchers-invent-process-for-3d-printing-complex-transparent-glass-forms/

9.6 The ‘chemputer’ that could print out any drug

Larry H. Bernstein, MD

http://pharmaceuticalintelligence.com/2015/09/10/drug-chemputer/

9.7 3-D-Bioprinting in use to Create Cardiac Living Tissue: Print your Heart out

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2015/03/16/3-d-bioprinting-in-use-to-create-cardiac-living-tissue-print-your-heart-out/

9.8 LPBI’s Perspective on Medical and Life Sciences Applications – 3D Printing: BioInks, BioMaterials-BioPolymer

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2015/08/12/lpbis-perspective-on-medical-and-life-sciences-applications-3d-printing-bioinks-biomaterials-biopolymer/

9.9 Medical MEMS, Sensors and 3D Printing: Frontier in Process Control of BioMaterials

Curators: Aviva Lev-Ari, PhD, RN and Adam Sonnenberg, BSc

http://pharmaceuticalintelligence.com/2015/08/10/medical-mems-sensors-and-3d-printing-frontier-in-process-control-of-biomaterials/

9.10 NIH and FDA on 3D Printing in Medical Applications: Views for On-demand Drug Printing, in-Situ direct Tissue Repair and Printed Organs for Live Implants

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2015/07/27/nih-and-fda-on-3d-printing-in-medical-applications-views-for-on-demand-drug-printing-in-situ-direct-tissue-repair-and-printed-organs-for-live-implants/

9.11 ‘Pop-up’ fabrication technique trumps 3D printing

Aviva Lev-Ari, PhD, RN

http://pharmaceuticalintelligence.com/2015/01/14/pop-up-fabrication-technique-trumps-3d-printing/

Share this:

  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Facebook (Opens in new window) Facebook
  • Print (Opens in new window) Print
  • Email a link to a friend (Opens in new window) Email

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 2,056 other subscribers
  • Recent Posts

    • Grok thinks like PhDs – Hybrid Model for Autonomous Update of Doctoral Dissertations with Original PhD Student Author editing and acceptance of Grok’s updated output. 3rd Joint article, a pilot study for Validation of an Autonomous Journal Articles Updating System (AJAUS) tested on Autonomous Update of Aviva Lev-Ari, PhD, RN Doctoral Thesis, UC, Berkeley, 1983. January 31, 2026
    • 2026 World Economic Forum, 1/19 – 1/23/2026, Davos, Switzerland, LPBI Group’s KOLs interpretation of AI in Health Videos January 24, 2026
    • Evolving LPBI Group’s Portfolio of Intellectual Properties (IP): From 2021 Vision to 2026 Reality January 12, 2026
    • Aviva Lev-Ari, PhD, RN – Biography ->> Grokepedia Entry January 11, 2026
    • List of Articles included in the Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Article SELECTION from Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com for Training Small Language Models (SLMs) in Domain-aware Content of Medical, Pharmaceutical, Life Sciences and Healthcare by 15 Subjects Matter January 10, 2026
    • Collection of Aviva Lev-Ari, PhD, RN Scientific Articles on PULSE on LinkedIn.com January 10, 2026
    • The youngest leader in AI in Health: Tanishq Mathew Abraham, Ph.D. (@iScienceLuvr) January 8, 2026
    • 2026 Grok Multimodal Causal Reasoning on Proprietary Cariovascular Corpus: From 2021 Wolfram NLP Baseline to Thousands of Novel Relationships – A Second Head-to-Head Validation of LPBI’s Domain-Aware Training Advantage January 6, 2026
    • Workflow for Dynamic Linkage and Transition between two Authoring Systems: LPBI Group’s WordPress.com Multi-Authors Authoring System and Microsoft PowerPoint product for Slide show presentation – Part 10.1 in Composition of Methods January 6, 2026
  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • 1 2012pharmaceutical
    • 1 sjwilliamspa

Powered by WordPress.com.

WPThemes.


%d